Objective: We aimed to clarify the possible contributions of TRP and voltagedependent
K+ channels to the analgesic effects of diclofenac, ketoprofen, etodolac,
and dipyrone using the nonselective TRP channel blocker ruthenium red and the
voltage-dependent K+ channel blocker (Kv7; KCNQ) XE 991, respectively.
Methods: We assessed the changes in the antinociceptive effects of diclofenac (50
mg/kg, i.p.), ketoprofen (50 mg/kg, i.p.), etodolac (70 mg/kg, i.p.), and dipyrone (500
mg/kg, i.p.) using ruthenium red (3 mg/kg, i.p.) and XE 991 (1 mg/kg, i.p.) before
treatment in the hot plate, tail immersion, and writhing tests in mice.
Results: In the tail immersion test, ruthenium red administration resulted in a
significant reversal in the analgesic effects of dipyrone, etodolac, and ketoprofen. In
the hot plate test, a significant reversal was observed in the analgesic effect of only
dipyrone. In the tail immersion test, the administration of XE 991 induced a significant
reversal in the analgesic effects of dipyrone and etodolac and a relative reversal in the
analgesic effects of ketoprofen and diclofenac. In the hot plate test, XE 991 produced
a significant reversal in the analgesic effect of only ketoprofen, whereas it caused a
relative reversal in the analgesic effects of other tested nonsteroidal anti-inflammatory
drugs (NSAIDs). In the writhing test, no significant change was observed after either
XE 991 or ruthenium red administration.
Concusions: Modulation of TRP and K+ channels may be involved in the central
analgesic effects of NSAIDs. The clarification of different action mechanisms of
NSAIDs will contribute to new therapeutic approaches and provide guidance for new
drug development studies.
Primary Language | English |
---|---|
Journal Section | Articles |
Authors | |
Publication Date | December 28, 2018 |
Submission Date | November 10, 2017 |
Published in Issue | Year 2018 Volume: 8 Issue: 4 |